| Term 
 | Definition 
 
        | Drug class Loop Diuretics
 MOA
 Inhibitors of Na+-K+-2Cl– symport in the thick ascending limb of loop of henle
 Uses
 acute pulmonary edema
 chronic congestive heart failure
 Edema
 Side effects/contraindications
 Hypokalemia
 Dehydration
 Ototoxicity
 Sulfa related
 |  | 
        |  | 
        
        | Term 
 
        | Hydrochlorothiazide (HCTZ) |  | Definition 
 
        | Drug class Thiazide diuretics
 MOA
 Inhibitors of Na+-Cl– symport in distal tubule
 Uses
 Edema
 HTN
 Side effects/contraindications
 Hypokalemia
 Dehydration
 Sulfa related
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Potassium-sparing diuretics
 MOA
 Na+ channel blockade in late distal tubule
 Uses
 Major utility is in combination with other diuretics for edema or HTN
 Side effects/contraindications
 Hyperkalemia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Aldosterone Antagonists, K+-Sparing Diuretics
 MOA
 Competitively inhibit the binding of aldosterone to the MR
 Uses
 Combination with other diuretics for edema or HTN
 Hepatic cirrhosis
 CHF
 Side effects/contraindications
 Hyperkalemia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Angiotensin-Converting Enzyme Inhibitors
 MOA
 Inhibit the conversion of Ang I to the active Ang II
 Uses
 HTN, CHF, Post-MI, Diabetes Mellitus
 Side effects/contraindications
 Contraindicated African Americans for HTN use
 Contraindicated pregnancy
 Cough (Bradykinins)
 Hyperkalemia
 Hypotension
 Acute Renal Failure
 Angioedema
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Angiotensin II Receptor Antagonists
 MOA
 Bind to the AT1 receptor with high affinity
 Uses
 HTN
 CHF
 Diabetes mellitus
 Side effects/contraindications
 Angioedema and cough with ARBs is less than that with ACE inhibitors
 Contraindicated pregnancy
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Direct Renin Inhibitors
 MOA
 Binds the active site of renin to block conversion of angiotensinogen to Ang I
 Uses
 HTN
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Organic Nitrates
 MOA
 NO-dependent relaxation of vascular smooth muscle leads to vasodilation
 Uses
 Acute Angina
 CHF
 Side effects/contraindications
 Headache
 Hypotension
 Interaction of Nitrates with PDE5 Inhibitors (ED)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Organic Nitrates
 MOA
 NO-dependent relaxation of vascular smooth muscle leads to vasodilation
 Uses
 Chronic Angina
 Side effects/contraindications
 Headache
 Hypotension
 Interaction of Nitrates with PDE5 Inhibitors (ED)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Ca2+ Channel Antagonists (CCB)
 MOA
 Relax arterial smooth muscle
 Uses
 Prinzmals angina
 HTN
 Raynauds phenomenon
 Side effects/contraindications
 Edema
 GERD
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Ca2+ Channel Antagonists (CCB)
 MOA
 Depress the rate of the sinus node pacemaker and slow AV conduction
 Uses
 Supraventricular tachyarrhythmias
 Side effects/contraindications
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class b Adrenergic Blockers
 MOA
 Slow the heart rate and decrease myocardial contractility
 Uses
 Unstable angina, MI, CHF, HTN, Performance anxiety
 Hyperthyroidism, Glaucoma – drops, Migraine prevention
 Contraindications
 Asthma and COPD
 b2 receptor blockades
 Raynaud’s syndrome, Depression, Severe PVD, Sinus bradycardia
 AV block, Diabetes, Anaphylaxis Hx
 Side effects
 Fatigue
 Erectile dysfunction
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class a1 Adrenergic Receptor Antagonists
 MOA
 Blockade of a1 adrenergic receptors inhibits vasoconstriction induced by endogenous catecholamines
 Uses
 HTN
 Benign Prostatic Hypertrophy (BPH)
 Side effects/contraindications
 Marked postural hypotension and syncope sometimes occur
 “Floppy” cataract with tamsulosin (Flomax)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class a2-Selective Adrenergic Receptor Agonists
 MOA
 Activation of a2 receptors in the cardiovascular control centers of the CNS suppresses the outflow of sympathetic nervous system activity
 Uses
 HTN (Pregnancy first-line, HTN crisis)
 ADHD side effects
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Vasodilators
 MOA
 Directly relaxes arteriolar smooth muscle
 Uses
 HTN
 Side effects/contraindications
 headache,
 nausea,
 flushing,
 hypotension,
 drug-induced lupus syndrome
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Cardiac Glycosides
 MOA/Uses
 Inhibition of the plasma membrane Na+, K+-ATPase in myocytes
 A positive inotropic effect on the failing myocardium (CHF)
 Suppression of rapid ventricular rate response in CHF-associated atrial fibrillation
 Regulation of downstream deleterious effects of sympathetic nervous system over-activation
 Side effects/contraindications
 Digoxin Toxicity
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Class 1 Anti-Arrhythmic
 MOA
 Na+ channel block
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Class 2 Anti-Arrhythmic
 MOA
 b blockade
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Class 3 Anti-Arrhythmic
 MOA
 action potential prolongation (usually by K+ channel block)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Class 4 Anti-Arrhythmic
 MOA
 Ca2+ channel block
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Statins
 MOA
 Inhibition of HMG-CoA reductase decreases the bodies de novo synthesis of cholesterol primarily in the liver.
 Uses
 Hyperlipidemia
 Side effects/contraindications
 liver dysfunction
 rhabdomyolysis
 Extreme caution with combination statin and fibrate
 |  | 
        |  | 
        
        | Term 
 
        | Cholestyramine (Questran) |  | Definition 
 
        | Drug class Resins
 MOA
 sequester bile acids and bile salts from being absorbed by the ileum and are consequently eliminated in the feces
 Uses
 Hyperlipidemia
 Bile salt–induced diarrhea
 Side effects/contraindications
 Upset GI
 Decreased absorption of drugs and fat soluble vitamins
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Niacin
 MOA
 Niacin impairs of the release and synthesis of VLDL by the liver
 Uses
 Hyperlipidemia
 Side effects/contraindications
 Cutaneous flush
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Fibrates
 MOA
 increase in lipolysis and decrease in VLDL levels by acting as ligands for the peroxisome proliferator-activated receptor (PPAR).
 Uses
 Hyperlipidemia
 Side effects/contraindications
 liver dysfunction
 rhabdomyolysis
 Extreme caution with combination statin and fibrate
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Absorption Inhibitors
 MOA
 decrease the intestinal uptake of dietary and liver excreted cholesterol.
 Uses
 Hyperlipidemia
 |  | 
        |  | 
        
        | Term 
 
        | Albuterol (Ventolin)(inhaled) |  | Definition 
 
        | Drug class Short acting B2-agonist
 MOA
 relax airway smooth muscle and cause a prompt increase in airflow and reduction of symptoms
 Uses
 Acute asthma – first line
 Side effects/contraindications
 Tachycardia
 |  | 
        |  | 
        
        | Term 
 
        | Ipratropium bromide(inhaled) |  | Definition 
 
        | Drug class Anticholinergics
 MOA
 Reverse vagally mediated bronchospasm but not allergen- or exercise-induced bronchospasm
 Uses
 Acute COPD – first line
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Inhaled corticosteroid
 MOA
 reduce both acute and chronic inflammation
 Uses
 Preventative asthma – first line
 Preventative COPD – second line
 Side effects/contraindications
 Mouth washing after use decreases local side effects (cough, dysphonia, oropharyngeal candidiasis) and systemic absorption
 Systemic effects may occur with high-dose inhaled corticosteroid therapy.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Mediator inhibitors
 Uses
 Exercised-induced asthma
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Long acting B2 agonist
 MOA
 bronchodilation for up to 12 hours after a single dose
 Uses
 Preventative COPD - First-line but more effective as combination with inhaled steroid
 Preventative asthma when used with inhaled steroid
 Side effects/contraindications
 NEVER use alone for preventative asthma
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Phosphodiesterase inhibitors
 MOA
 mild bronchodilation
 anti-inflammatory and immunomodulatory properties,
 enhances mucociliary clearance,
 strengthens diaphragmatic contractility
 Uses
 Preventative Asthma – last resort
 Preventative COPD – last resort
 Side effects/contraindications
 narrow toxic-therapeutic range
 Many side effects
 |  | 
        |  | 
        
        | Term 
 
        | Montelukast (Singulair)(oral) |  | Definition 
 
        | Drug class Leukotriene modifiers
 MOA
 Leukotriene receptor antagonists
 Uses
 Preventative asthma – 2nd or 3rd line
 Allergic rhinitis
 |  | 
        |  | 
        
        | Term 
 
        | Tiotropium (Spiriva)(inhaled) |  | Definition 
 
        | Drug class Anticholinergics
 Uses
 Preventative COPD – first line
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Systemic corticosteroids
 MOA/Uses
 Metabolic
 Anti-inflammatory
 Immunosuppressive
 Side effects/contraindications
 diabetes-like state due to increases in blood glucose
 fat deposition and redistribution to face and trunk
 muscle wasting/weakness
 ulceration/PUD
 osteoporosis (increased osteoclast activity)
 increase susceptibility to infection (immune suppression)
 decrease wound healing
 glaucoma/cataracts (due to impaired aqueous humor flow)
 Acne, HTN
 Additional
 Must be tapered if past 7-10 days of treatment
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Estrogen/progesterone oral HRT
 MOA
 replace estrogen in blood stream
 decrease bone resorption
 Uses
 amelioration of vasomotor symptoms
 the prevention of bone fractures
 prevention of urogenital atrophy.
 Side effects/contraindications
 adverse cardiovascular effects, including hypertension, myocardial infarction, hemorrhagic or ischemic stroke in presence of risk factors
 venous thrombosis and embolism
 breast, hepatocellular, and cervical cancers in presence of risk factors
 gallbladder disease
 Additional
 Combination must be used if uterus still present
 Estrogen-only acceptable if complete hysterectomy
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Estrogen/progesterone combination OCP
 MOA
 Prevent ovulation by suppressing FSH and LH – 99.9% effective
 Uses
 Birth control
 Ovarian cysts
 Acne
 Dysmenorrhea & menorrhagia
 Side effects/contraindications
 adverse cardiovascular effects, including hypertension, myocardial infarction, hemorrhagic or ischemic stroke in presence of risk factors
 venous thrombosis and embolism
 breast, hepatocellular, and cervical cancers in presence of risk factors
 gallbladder disease
 decrease lactation in nursing mothers
 Benefits
 Reduced endometrial and ovarian cancer
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Progesterone-only OCP
 MOA
 Prevent ovulation by suppressing FSH and LH
 Thickening of cervical mucus, which decreases sperm penetration,
 Endometrial alterations that impair implantation;
 Uses
 Birth control – good choice for nursing mothers
 Progestin challenge test in amenorrhea
 Side effects/contraindications
 Break through bleeding
 Mood changes
 Weight gain
 Headaches
 Decrease HDL and increase LDL
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class/MOA muscarinic receptor antagonists
 Uses
 Overactive bladder
 Enuresis in children
 Increase bladder capacity in spastic paraplegia
 Side effects
 Red as a beat
 bronchodilation
 Dry as a bone
 dry mouth, dry red hot skin, dry eyes
 Mad as a hatter
 CNS confusion, delirium, hallucinations and seizures
 Blind as a bat
 dilated pupils (mydriasis) and cycloplegia (paralysis of accommodation),
 Contraindications
 urinary tract obstruction,
 GI obstruction,
 uncontrolled (or susceptibility to attacks of) angle-closure glaucoma
 BPH (caution)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Antitussive
 MOA
 centrally active N-methyl-D-aspartate (NMDA) receptor antagonist.
 Uses
 Cough – not effective – OTC
 Interactions with dextromethorphan
 Triptans
 MAOI’s
 SSRI’s (Fluoxetene &Paroxetine)
 Memantine (Namenda)
 |  | 
        |  | 
        
        | Term 
 
        | BENZONATATE (Tessalon pearls) |  | Definition 
 
        | Drug class Antitussive
 MOA
 A local anesthetic, acts peripherally by anesthetizing the stretch receptors located in the respiratory passages, lungs, and pleura
 Uses
 Cough
 Side effects/contraindications
 Caution with children
 Ester-type anesthetic (tetracaine) hypersensitivity with benzonatate
 |  | 
        |  | 
        
        | Term 
 
        | Guaifenesin (Robitussin/Mucinex) |  | Definition 
 
        | Drug class Expectorant
 MOA
 increase secretions, reduce viscosity and help to expel sputum
 Uses
 Help loosen phlegm and thin bronchial secretions to make coughs more productive
 Side effects
 Nausea, vomiting and diarrhea
 Runny nose
 Drowsiness, dizziness and headache
 Contraindications or Caution:
 Persistent or chronic cough
 Asthmatics (prone to bronchospasm)
 CV disease and HTN
 Pregnancy & lactation
 |  | 
        |  | 
        
        | Term 
 
        | Pseudoephedrine (Sudafed) |  | Definition 
 
        | Drug class Decongestant
 MOA/Uses
 Constrict blood vessels in the respiratory tract, resulting in shrinkage of swollen mucous membranes and helping open the nasal airway passages
 Directly stimulates alpha 1-adrenergic receptors of respiratory mucosa causing vasoconstriction;
 Directly stimulates beta-adrenergic receptors causing bronchial relaxation, increased heart rate and contractility
 Side effects
 Anxiety, nervousness, tremor and seizures, Palpitations, Headache, Cerebral hemorrhage
 Reduced cardiac and reduced urine output
 Dizziness, Excitability, Insomnia, Restlessness
 Elevated blood pressure
 Contraindications or extreme caution:
 CV disorders, Hyperthyroid or Diabetes
 Older adults – especially those with glaucoma or BPH
 Pregnancy or lactation & Hypertension
 Use with caution in patients with
 asthma, bowel obstruction/narrowing & elderly
 |  | 
        |  | 
        
        | Term 
 
        | Diphenhydramine (Benadryl) |  | Definition 
 
        | Drug class/MOA First generation H1 antagonist (ethanolamines)
 Uses
 Allergic diseases & pruritus
 Sedation/Insomnia
 Anxiety
 Motion sickness
 Side effects
 Sedation
 Contraindications/caution
 COPD and asthma
 Persons operating machinery or driving
 Older adult patients (extended half life)
 CV disorders
 BPH
 Infants
 Seizure disorders
 |  | 
        |  | 
        
        | Term 
 
        | Hydroxyzine (Vistaril or Atarax) |  | Definition 
 
        | Drug class/MOA First generation H1 antagonist (piperazines)
 Uses
 Allergic diseases & pruritus
 Sedation/Insomnia
 Anxiety
 Side effects
 Sedation
 Contraindications/caution
 COPD and asthma
 Persons operating machinery or driving
 Older adult patients (extended half life)
 CV disorders
 BPH
 Infants, pregnancy, lactation
 Seizure disorders
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class/MOA First generation H1 antagonist (piperazines)
 Uses
 Motion sickness
 Vertigo
 Side effects
 Sedation
 Contraindications/caution
 COPD and asthma
 Persons operating machinery or driving
 Older adult patients (extended half life)
 CV disorders
 BPH
 Infants, pregnancy, lactation
 Seizure disorders
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class/MOA First generation H1 antagonist (phenothiazines)
 Anticholinergic activity
 Uses
 Motion sickness
 Nausea/emesis
 Vertigo
 Side effects
 Sedation
 Anticholinergic side effects
 Contraindications/caution
 COPD and asthma
 Persons operating machinery or driving
 Older adult patients (extended half life)
 CV disorders
 BPH
 Infants, pregnancy, lactation
 Seizure disorders
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class/MOA Second generation H1 antagonist (piperazines)
 Non-drowsy
 Uses
 Allergic rhinitis
 Side effects/contraindications
 Caution in infants, pregnancy and nursing mothers
 May still cause sedation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Uses Hypoxia
 Heart and lung disease
 Carbon monoxide poisoning
 CNS conditions with resp. difficulty/failure
 Side effects
 Hypoventilation (particularly with COPD)
 May cause CO2 retention and acidosis
 Confusion
 Changes in the alveoli of the lungs
 Blindness (in premature infants)
 Cautions:
 Patients with COPD (high O2 conc. May cause hypoventilation or apnea)
 Danger of fire
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Extended-Spectrum Penicillins
 MOA
 peptidoglycan synthesis is inhibited in the cell wall resulting in cell lysis
 Uses
 Bacterial infection
 Gram + and some gram –
 NOT for staph aureus
 Side effects/contraindications
 The frequency of IgE cross-allergy between cephalosporins and penicillins approximates 5–10%.
 |  | 
        |  | 
        
        | Term 
 
        | Amoxicillin/clavulanic acid (Augmentin) |  | Definition 
 
        | Drug class Penicillins Combined with B-Lactamase Inhibitors
 MOA
 peptidoglycan synthesis is inhibited in the cell wall resulting in cell lysis
 b-lactamase inhibitor
 Uses
 Bacterial infection
 Gram + and some gram –
 Staphylococcus aureus, H influenzae, Moraxella catarrhalis, and B fragilis.
 Side effects/contraindications
 Most commonly associated with diarrhea
 The frequency of IgE cross-allergy between cephalosporins and penicillins approximates 5–10%.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Antistaphylococcal Penicillins
 MOA
 peptidoglycan synthesis is inhibited in the cell wall resulting in cell lysis
 Uses
 Bacterial infections
 Staph aureus
 group A streptococci in skin and soft tissue infections
 NOT effective against other gram + bacteria
 Side effects/contraindications
 The frequency of IgE cross-allergy between cephalosporins and penicillins approximates 5–10%.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class 1st generation cephalosporin
 MOA
 inhibition of cell wall synthesis,
 activation of autolytic enzymes in the cell wall
 Uses
 Bacterial infections
 Gram + mostly
 Staph aureus
 Group A hemolytic streptococci
 E coli, Klebsiella pneumoniae
 NOT H influenzae or penicillin-resistant streptococci
 Side effects/contraindications
 The frequency of IgE cross-allergy between cephalosporins and penicillins approximates 5–10%.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class 2nd generation cephalosporin
 MOA
 inhibition of cell wall synthesis,
 activation of autolytic enzymes in the cell wall
 Uses
 Bacterial infections
 Gram + with some extended coverage to gram –
 NOT Pseudomonas aeruginosa
 Side effects/contraindications
 The frequency of IgE cross-allergy between cephalosporins and penicillins approximates 5–10%.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class 3rd generation cephalosporin
 MOA
 inhibition of cell wall synthesis,
 activation of autolytic enzymes in the cell wall
 Uses
 Bacterial infections
 Mostly gram – with some gram +
 Inhibit most streptococci
 Staph aureus (not as good as 1st generation)
 Gonorrhea
 Side effects/contraindications
 The frequency of IgE cross-allergy between cephalosporins and penicillins approximates 5–10%.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Macrolides
 MOA
 Inhibit protein synthesis by binding to the 50S subunit of bacterial ribosomes.
 Uses
 Bacterial infections
 streptococcal and pneumococcal disease
 Legionella, Mycoplasma, and Chlamydia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Macrolides
 MOA
 Inhibit protein synthesis by binding to the 50S subunit of bacterial ribosomes.
 Uses
 Bacterial infections
 streptococcal and pneumococcal disease
 Legionella, Mycoplasma, and Chlamydia
 Side effects/contraindications
 prolongation of the QT interval and torsades de pointes
 increase the effects of oral anticoagulants, digoxin, theophylline, and cyclosporine by inhibiting cytochrome P450
 must stop Statin while taking
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Tetracyclines
 MOA
 inhibitors of protein synthesis
 Uses
 Bacterial infections
 Many gram + and gram –
 Staph aureus, including MRSA (second choice)
 Antipneumococcal & H influenzae activity
 Chlamydia
 Acne
 Side effects/contraindications
 absorption is impaired by dairy products and aluminum hydroxide gels (antacids)
 photosensitization
 avoid at bedtime due to the risk of esophageal erosion.
 should not be given to pregnant or nursing women
 teeth discoloration
 children under 8 years of age
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Aminoglycosides
 MOA
 inhibit the function of the 30S subunit of the bacterial ribosome
 Uses
 Bacterial infections
 Topical, ear, and eye
 Side effects/contraindications
 ototoxic
 nephrotoxic
 not absorbed from the gastrointestinal tract
 |  | 
        |  | 
        
        | Term 
 
        | Trimethoprim/sulfamethoxazole(Bactrim DS or Septra DS) |  | Definition 
 
        | Drug class Sulfonamides
 MOA
 structural analogs of p-aminobenzoic acid (PABA) and compete with PABA to block its conversion to dihydrofolic acid.
 Organisms that utilize PABA in the synthesis of folates and pyrimidines are inhibited
 Uses
 Bacterial infections
 Gram –
 E. coli
 Staph aureus including MRSA (1st choice)
 Side effects/contraindications
 Because of the risk of Stevens-Johnson syndrome, patients with a previous rash after trimethoprim-sulfamethoxazole should not receive the drug again
 |  | 
        |  | 
        
        | Term 
 
        | Mupirocin (Bactroban) topical |  | Definition 
 
        | MOA inhibits protein synthesis by binding to bacterial isoleucyl-tRNA synthetase.
 Uses
 Bacterial infections
 Gram +
 Staph aureus including MRSA
 Most streptococci
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Uses Bacterial infections
 Gram +
 Most anaerobes
 S pneumoniae
 Group A streptococci,
 S aureus including MRSA (2nd choice)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Uses Bacterial infections
 anaerobic gram-negative bacilli
 minimal activity against anaerobic gram-positive
 Protozoal infections
 Side effects/contraindications
 EtOH
 Ingestion of alcohol results in a disulfiram reaction
 Reversible peripheral neuropathy
 Decrease the metabolism of warfarin (Coumadin)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Uses Bacterial infections
 Broad spectrum (“big guns”)
 Oral for antibiotic-associated enterocolitis
 Side effects/contraindications
 not absorbed from the gastrointestinal tract
 hyperemia ("red man syndrome") from rapid infusion
 pretreating with H1 antagonist can help
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Quinolones
 MOA
 inhibition of bacterial DNA synthesis by blocking the enzyme DNA gyrase
 Uses
 Bacterial infections (Broad spectrum)
 Gram – with limited gram +
 Pseudomonas aeruginosa
 Side effects/contraindications
 Prolong the QT interval
 Decrease the metabolism of warfarin (Coumadin)
 Not to be used in children
 Black Box warnings
 Tendinitis/Tendon rupture
 Avoid in Myasthenia Gravis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Quinolones
 MOA
 inhibition of bacterial DNA synthesis by blocking the enzyme DNA gyrase
 Uses
 Bacterial infections (Broad spectrum)
 Gram – with good gram +
 Pseudomonas aeruginosa
 NOT MRSA or Chlamydia (due to resistance)
 Side effects/contraindications
 Prolong the QT interval
 Decrease the metabolism of warfarin (Coumadin)
 Not to be used in children
 Black Box warnings
 Tendinitis/Tendon rupture
 Avoid in Myasthenia Gravis
 |  | 
        |  | 
        
        | Term 
 
        | Nitrofurantoin (Macrobid) |  | Definition 
 
        | Uses Bacterial infections (urinary only)
 UTI
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Antifungal
 Uses
 Superficial candidal infections
 Thrush
 Diaper rash
 Intertrigo
 Side effects/contraindications
 drug is not absorbed from mucous membranes or the gastrointestinal tract
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Antifungal
 Uses
 Fungal infections
 Side effects/contraindications
 Monitor liver function
 Must stop Statin while taking
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Antifungal
 MOA
 inhibit synthesis of ergosterol, resulting in inhibition of membrane-associated enzyme activity, cell wall growth, and replication.
 Uses
 Fungal infections
 Seborrheic dermatitis
 Side effects/contraindications
 Monitor liver function
 Must stop Statin while taking
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class/MOA Neuraminidase inhibitors
 Uses
 prevention and treatment of influenza A and B
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Antiviral
 MOA
 selectively active against viral DNA polymerase and thus inhibits virus proliferation
 Uses
 herpes simplex virus
 varicella-zoster virus
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Proton Pump Inhibitors
 MOA
 Inhibit the gastric H+, K+-ATPase (proton pump)
 Uses
 GERD, gastritis, gastric ulcer
 Side effects/contraindications
 Can interact adversely with clopidogrel (Plavix)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class H2 Receptor Antagonists
 MOA
 inhibit acid production by reversibly competing with histamine for binding to H2 receptors on the basolateral membrane of parietal cells
 Uses
 GERD, gastritis, gastric ulcer
 Allergic disease
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Prokinetic Agents
 MOA
 serotonin (5-HT)-4 receptor agonist
 vagal and central 5-HT3 antagonism
 dopamine-2 receptor antagonist
 Uses
 Gastroparesis
 Nausea/emesis
 Side effects/contraindications
 Extrapyramidal effects (Parkinsonian symptoms)
 Dystonias and parkinsonian-like symptoms are reversible upon discontinuation of metoclopramide
 Tardive dyskinesia also can occur with chronic treatment (months to years) and may be irreversible.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class/MOA 5-HT3 Receptor Antagonists
 Uses
 Chemotherapy-induced nausea
 Nausea secondary to upper abdominal irradiation
 Hyperemesis of pregnancy
 Postoperative nausea
 |  | 
        |  | 
        
        | Term 
 
        | Prochlorperazine (Compazine) |  | Definition 
 
        | Drug class Dopamine-Receptor Antagonists
 MOA
 D2 receptor antagonism at the CTZ
 Uses
 Nausea/emesis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Bulk forming agents
 MOA
 Absorb water and increase fecal bulk.
 Increase colonic bacterial mass through fermentation
 Uses
 Constipation
 Side effects/contraindications
 Bloating
 Avoid in obstruction and megacolon
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Stool softeners
 MOA
 Lowers the surface tension of the stool to allow mixing of aqueous and fatty substances, softening the stool and permitting easier defecation.
 Uses
 Constipation
 |  | 
        |  | 
        
        | Term 
 
        | polyethylene glycol 3350 (Miralax) |  | Definition 
 
        | Drug class Osmotic laxative
 MOA
 osmotically mediated water retention, which then stimulates peristalsis
 Uses
 Constipation
 Bowel prep (electrolyte version)
 Side effects/contraindications
 Electrolyte imbalance with large doses
 |  | 
        |  | 
        
        | Term 
 
        | magnesium hydroxide 	(Milk of magnesia) |  | Definition 
 
        | Drug class Saline osmotic laxative
 MOA
 Osmotically mediated water retention, which then stimulates peristalsis
 Uses
 Constipation
 Side effects/contraindications
 Electrolyte imbalance
 Caution
 renal insufficiency,
 cardiac disease,
 preexisting electrolyte abnormalities,
 patients on diuretic therapy
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Stimulant laxative
 MOA
 direct effects on enterocytes, enteric neurons, and GI smooth muscle
 Uses
 Constipation
 Side effects/contraindications
 Electrolyte imbalance
 “cathartic colon”
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOA enhance fluid secretion by acting locally on ion channels in the colonic epithelium to promote secretion
 prostanoid activator of Cl– channels
 Uses
 Constipation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOA anti-secretory,
 anti-inflammatory,
 antimicrobial effects
 Uses
 Diarrhea
 Nausea and GI cramps
 Side effects/contraindications
 Dark stools
 Black staining of the tongue
 Avoid
 Salicylate allergy
 Children due to Reye syndrome
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Anti-diarrheal (Opioid agonists)
 MOA
 Increases small intestinal and mouth-to-cecum transit times.
 Increases anal sphincter tone
 Uses
 Diarrhea
 Side effects/contraindications
 Avoid in active inflammatory bowel disease due to toxic megacolon
 |  | 
        |  | 
        
        | Term 
 
        | Diphenoxylate/atropine (Lomotil) |  | Definition 
 
        | Drug class Anti-diarrheal (Opioid agonists)
 MOA
 Increases small intestinal and mouth-to-cecum transit times.
 Increases anal sphincter tone
 Uses
 Diarrhea
 Side effects/contraindications
 Avoid in active inflammatory bowel disease due to toxic megacolon
 In high doses, these drugs cause CNS effects as well as anticholinergic effects from the atropine (dry mouth, blurred vision, etc.)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class ANTI-SPASMODICS
 MOA
 Nonspecific antagonists of the muscarinic receptor
 Uses
 IBS
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class SSRI
 MOA
 blocks reuptake of 5HT by SERT and results in enhanced and prolonged serotonergic neurotransmission.
 Uses
 Depression
 Generalized anxiety,
 Panic attack
 Social anxiety,
 Obsessive-compulsive disorder
 Premenstrual dysphoric syndrome (PMDD)
 Vasovagal symptoms in post-menopausal women
 Side effects/contraindications
 Black Box warning increased suicide risk in adolescents
 Serotonin syndrome
 ED/decreased libido
 Taper when discontinuing
 Avoid use with Triptans (migraine) and tramadol
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class SNRI
 MOA
 inhibit both SERT and NET
 Uses
 Depression
 Anxiety
 Pain (fibromyalgia, nerve pain)
 Off label uses
 stress urinary incontinence (duloxetine)
 Side effects/contraindications
 Black Box warning increased suicide risk in adolescents
 Serotonin syndrome
 ED/decreased libido
 Cymbalta unlikely to cause ED
 Taper when discontinuing
 Avoid use with Triptans (migraine) and tramadol
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOA Appears to inhibit NET
 It also blocks the DAT (dopamine)
 Uses
 depression,
 smoking cessation (ZYBAN brand).
 Side effects/contraindications
 Black Box warning
 1. increased suicide risk in adolescents
 2. Serious neuropsychiatric events, especially with smoking cessation
 Seizures at high doses
 Does NOT cause ED
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class TRICYCLIC ANTIDEPRESSANTS
 MOA
 Inhibit both SERT and NET
 Uses
 Depression
 Insomnia (low doses)
 Pain (low doses)
 Side effects/contraindications
 sedation
 cognitive dulling
 blurred vision,
 dry mouth,
 tachycardia,
 constipation,
 difficulty urinating
 orthostatic hypotension
 weight gain
 seizure
 cardiac conduction abnormalities
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Benzodiazepines (intermediate-acting)
 MOA
 enhance the inhibitory effects of the neurotransmitter
 Uses
 acute anxiety
 sedative/insomnia
 Side effects/contraindications
 sedation
 impair cognitive performance and memory,
 adversely affect motor control,
 slowed reaction time (which may lead to accidents)
 potentiate the effects of other sedatives including alcohol
 habit-forming
 withdrawal symptoms if not tapered
 caution with elderly
 Controlled substance
 Schedule IV
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Benzodiazepines (quick-acting)
 MOA
 enhance the inhibitory effects of the neurotransmitter GABA
 Uses
 acute anxiety
 muscle relaxant
 Side effects/contraindications
 sedation
 impair cognitive performance and memory,
 adversely affect motor control,
 slowed reaction time (which may lead to accidents)
 potentiate the effects of other sedatives including alcohol
 habit-forming
 withdrawal symptoms if not tapered
 caution with elderly
 Controlled substance
 Schedule IV
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOA Selective partial agonists at 5-HT1A receptors.
 Uses
 Chronic anxiety – GAD only
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Atypical antipsychotics
 MOA
 Blockade of dopamine receptors in the mesolimbic area
 Uses
 Schizophrenia, Mania (Bipolar), Treatment-resistant depression as an add-on
 Obsessive compulsive disorder (OCD) , Post-traumatic stress disorder (PTSD)
 Tourette’s - relates to reduced D2 neurotransmission in basal ganglia sites)
 Huntington’s disease, Autism
 Side effects/contraindications
 Black Box warning
 1. increased suicide risk in adolescents
 2. Elderly patients with dementia-related psychosis treated with antipsychotics are at an increased risk of death
 Extrapyramidal effects (EPS) (Parkinsonism)
 Akathisia, Tardive dyskinesia risk, Hyperprolactinemia, Sedation
 Weight gain to appetite stimulation, Orthostatic hypotension, Dyslipidemia
 Impairments in glycemic control, Ventricular arrhythmias and sudden cardiac death
 (Less for newer atypicals), Seizure, Neuroleptic malignant syndrome
 Mainly just typicals
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Uses Bipolar
 Side effects/contraindications
 Toxic at high doses – requires routine labs
 Hand tremor
 Seizures
 Significant weight gain
 Renal damage from long term use
 Thyroid dysfunction
 Allergic skin rash has been associated with Lithium use
 Interactions
 Diuretics
 ACE inhibitors
 NSAIDS
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Insomnia - Imidazopyridine
 MOA
 effects on the benzodiazepine site of the GABAA receptor
 Uses
 Insomnia
 NOT anxiety
 Side effects/contraindications
 “Morning hangover”
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Salicylates (NSAIDS)
 MOA
 inhibiting the prostaglandin synthase enzymes, colloquially known as the cyclooxygenases (COXs)
 irreversibly inhibits COX activity
 Uses
 antipyretic,
 analgesic,
 anti-inflammatory
 anti-platelet
 Side effects/contraindications
 GI ulcer
 Ototoxic
 Contraindicated in children and young adults <20 years of age with viral illness–associated fever
 Due to Reye syndrome
 |  | 
        |  | 
        
        | Term 
 
        | Ibuprofren (Motrin, Advil) |  | Definition 
 
        | Drug class NSAIDS
 MOA
 inhibiting the prostaglandin synthase enzymes, colloquially known as the cyclooxygenases (COXs)
 Uses
 antipyretic,
 analgesic,
 anti-inflammatory
 Side effects/contraindications
 Black box warning
 1. GI ulcer
 2. Increased heart attack and stroke
 renal and renovascular adverse events
 NEPHROPATHY
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class COX-2 inhibitor NSAID
 MOA
 inhibiting the prostaglandin synthase enzymes, colloquially known as the cyclooxygenases (COXs)
 COX-2 only with minimal to no COX-1
 Uses
 antipyretic,
 analgesic,
 anti-inflammatory
 Side effects/contraindications
 Black box warning
 1. GI ulcer
 2. Increased heart attack and stroke
 renal and renovascular adverse events
 NEPHROPATHY
 |  | 
        |  | 
        
        | Term 
 
        | Acetaminophen (APAP) (Tylenol) |  | Definition 
 
        | MOA inhibiting the prostaglandin synthase enzymes, colloquially known as the cyclooxygenases (COXs)
 Only 50%
 Uses
 antipyretic,
 analgesic,
 Side effects/contraindications
 Acute liver failure
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MOA Some activity at opioid receptor
 Somewhat inhibits 5HT and NE reuptake
 Uses
 Pain control
 Side effects/contraindications
 Increased suicide risk in adolescents
 Seizures
 Dependence may occur
 Avoid SSRI, SNRI, and triptans (migraines)
 NOT controlled substance
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Opioid agonist (very strong)
 MOA
 Binds to various opioid receptors, producing analgesia and sedation
 Uses
 Pain control
 Side effects/contraindications
 May cause QT prolongation
 Taper chronic use
 Nausea/emesis
 Constipation
 Respiratory depression
 Sedation
 Avoid driving or operating machinery
 Cardiovascular side effects
 Controlled substance
 Schedule II
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Opioid agonist (very strong)
 MOA
 Binds to various opioid receptors, producing analgesia and sedation
 Uses
 Pain control
 Side effects/contraindications
 Taper chronic use
 Nausea/emesis
 Constipation
 Respiratory depression
 Sedation
 Avoid driving or operating machinery
 Cardiovascular side effects
 Controlled substance
 Schedule II
 |  | 
        |  | 
        
        | Term 
 
        | Oxycodone/APAP (Percocet) |  | Definition 
 
        | Drug class Opioid agonist (moderate strength)
 MOA
 Binds to various opioid receptors, producing analgesia and sedation
 Uses
 Pain control
 Side effects/contraindications
 Taper chronic use
 Nausea/emesis
 Constipation
 Respiratory depression
 Sedation
 Avoid driving or operating machinery
 Cardiovascular side effects
 Controlled substance
 Schedule II
 |  | 
        |  | 
        
        | Term 
 
        | Hydrocodone/APAP (Vicodin) |  | Definition 
 
        | Drug class Opioid agonist (Mild strength)
 MOA
 Binds to various opioid receptors, producing analgesia and sedation
 Uses
 Pain control
 Side effects/contraindications
 Taper chronic use
 Nausea/emesis
 Constipation
 Respiratory depression
 Sedation
 Avoid driving or operating machinery
 Cardiovascular side effects
 Controlled substance
 Schedule III
 |  | 
        |  | 
        
        | Term 
 
        | Codeine/APAP (Tylenol #3) |  | Definition 
 
        | Drug class Opioid agonist (Weakest)
 MOA
 Binds to various opioid receptors, producing analgesia and sedation
 Uses
 Pain control
 Side effects/contraindications
 Taper chronic use
 Nausea/emesis
 Constipation
 Respiratory depression
 Sedation
 Avoid driving or operating machinery
 Cardiovascular side effects
 Controlled substance
 Schedule III
 |  | 
        |  | 
        
        | Term 
 
        | Cyclobenzaprine (Flexeril) |  | Definition 
 
        | Drug class Muscle relaxants
 MOA
 Centrally active muscle relaxant – possible through sedation effects
 Uses
 Muscle spasms
 Side effects/contraindications
 Sedation
 Avoid driving and operating machinery
 Respiratory depression
 NOT controlled substance
 |  | 
        |  | 
        
        | Term 
 
        | Levothyroxine (Synthroid) |  | Definition 
 
        | Drug class Thyroid replacement
 MOA
 Replaces thyroid hormone thyroxine (T4)
 Uses
 Hypothyroidism
 Depression (off-label)
 Side effects/contraindications
 Cholestyramine, iron, fiber, antacids all decrease absorption of levothyroxine
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Anti-thyroid medications
 MOA
 inhibits TH synthesis by preventing oxidation of iodide and preventing the coupling of iodinated tyrosines into MIT and DIT
 PTU also prevents peripheral conversion of T4 into T3
 Uses
 Hyperthyroidism
 Preferred for pregnancy-related hyperthyroidism
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Sulfonylurea
 MOA
 Closes K+ channel in b-cell which stimulates insulin release from pancreas
 Uses
 Diabetes mellitus type 2
 Side effects/contraindications
 Hypoglycemia
 Weight gain – due to normal insulin physiology
 Caution in elderly
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Biguanide
 MOA
 primary action is on the liver, reducing hepatic gluconeogenesis
 Improves peripheral receptor sensitivity to insulin
 Uses
 Diabetes mellitus type 2
 Side effects/contraindications
 Lactic acidosis
 Caution in kidney disease
 Stop when using IV contrast
 GI disturbances (constipation or diarrhea)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Thiazolidinediones (TZDs)
 MOA
 sensitize peripheral tissues to insulin by up-regulating GLUT 4 receptors in the periphery by activating PPARg
 Uses
 Diabetes mellitus type 2
 Side effects/contraindications
 Edema
 Macular edema
 Contraindicated in CHF
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Incretins
 MOA
 GLP-1 receptor agonist that stimulates insulin release and decreases glucagon
 Uses
 Diabetes mellitus type 2
 Side effects/contraindications
 Weight loss
 Nausea
 Hypoglycemia (low risk)
 Severe pancreatitis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Incretins
 MOA
 DPP-4 inhibitor prolonging the action of endogenously released GLP-1which increases insulin release and decreases glucagon
 Uses
 Diabetes mellitus type 2
 Side effects/contraindications
 Nasopharyngitis
 Severe pancreatitis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Short-acting insulin
 MOA
 10-15 minute onset with peak 1 hour and duration 5-6 hours
 Uses
 Diabetes mellitus requiring insulin
 Side effects/contraindications
 Hypoglycemia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Long-acting insulin
 MOA
 3-4 hour onset, 8-10 hour peak (no real significant peak), and duration of 18-22 hours
 Uses
 Diabetes mellitus requiring insulin
 Side effects/contraindications
 Hypoglycemia (rare, if clinically possible)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Topical corticosteroid (low strength)
 MOA
 Immunosuppressive and anti-inflammatory
 Uses
 Eczema
 Pruritus
 Contact dermatitis
 Seborrheic dermatitis
 Side effects/contraindications
 Thinning of the skin
 Avoid on open wounds
 No prolonged use
 Avoid occlusion
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Topical corticosteroid (medium strength)
 MOA
 Immunosuppressive and anti-inflammatory
 Uses
 Eczema
 Pruritus
 Contact dermatitis
 Seborrheic dermatitis
 Side effects/contraindications
 Thinning of the skin
 Avoid on open wounds
 No prolonged use
 Avoid occlusion
 |  | 
        |  | 
        
        | Term 
 
        | Fluocinonide (Lidex) cream |  | Definition 
 
        | Drug class Topical corticosteroid (high strength)
 MOA
 Immunosuppressive and anti-inflammatory
 Uses
 Eczema
 Psoriasis
 Seborrheic dermatitis
 Side effects/contraindications
 Thinning of the skin
 Avoid on open wounds
 No longer than 2 week use
 Avoid face, groin, axilla
 Avoid occlusion
 |  | 
        |  | 
        
        | Term 
 
        | Halobetasol (Ultravate) cream |  | Definition 
 
        | Drug class Topical corticosteroid (ultra-high strength)
 MOA
 Immunosuppressive and anti-inflammatory
 Uses
 Psoriasis
 Seborrheic dermatitis
 Side effects/contraindications
 Thinning of the skin
 Avoid on open wounds
 No longer than 1 week use
 Avoid face, groin, axilla
 Avoid occlusion
 |  | 
        |  | 
        
        | Term 
 
        | TRETINOIN (Retin A) topical |  | Definition 
 
        | Drug class Topical Retinoids
 MOA
 Correct
 abnormal follicular keratinization,
 reduce P. acnes counts,
 reduce inflammation,
 Uses
 Acne
 Fine wrinkles
 Dyspigmentation
 Side effects/contraindications
 photosensitivity
 erythema,
 desquamation,
 burning,
 stinging
 avoid during pregnancy
 Benzoyl peroxide inactivates tretinoin and should not be applied simultaneously
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class 
 MOA
 interferes with insect sodium transport proteins, causing neurotoxicity and paralysis
 Uses
 Head lice
 Scabies
 Side effects/contraindications
 Slight local irritation, rash or conjunctivitis
 Dermatitis with frequent application
 |  | 
        |  | 
        
        | Term 
 
        | Silver sulfadiazine (Silvadene) (SSD) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Proparacaine (Alcaine) gtts |  | Definition 
 
        | Drug class Topical Anesthetic Agents
 Uses
 Measuring intraocular pressure
 Performing superficial surgery
 Evaluating a painful eye
 Side effects/contraindications
 Never Rx topical anesthetics
 Corneal ulcer with prolong use and delayed healing
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class Prostaglandin (PG) analog
 Uses
 Glaucoma (first-line)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug class synthetic DMARD
 Uses
 Rheumatoid arthritis – first-line
 Side effects/contraindications
 Stomatitis
 Cytopenia
 Hepatotoxicity
 Avoid EtOH and liver disease
 Side effects reduced by taking folate
 Avoid pregnancy – BOTH male and female
 |  | 
        |  |